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I. Supplementary Figures 
 
 
SI Figure 1. Gel electrophoresis of 
purified MACC1, S100A4, and G6PDH 
amplicons. Purified cDNA fragments for 
each gene were prepared using 50 ng of 
total RNA derived from SW620 cells, and 
treated with DNase I. In each case, the 
samples underwent gene-specific cDNA 
synthesis, were amplified by PCR and 
treated with RNase I. Then, the samples 
were further purified using the QIAquick 
PCR purification kit (Qiagen) according to 
the manufacturer’s instructions. cDNA 
fragments of expected sizes for each gene 
were obtained (1231 bp for G6PDH, 360 bp 
for MACC1 and 123 bp for S100A4). 
Negative control samples (-RT) were 
subjected to the same preparation 
procedure without the RT enzyme. The 
cDNA samples were separated in 4% 
PAGE, stained with SYBR Gold, and 






SI Figure 2. Ionic current after addition of a “-RT” sample to the nanopore. 10 minutes of 
continuous recording at 300 mV bias, after addition of a “-RT” sample (see SI Figure 1), shows 
that no non-specific translocation events occur in the absence of cDNA synthesis. The 






SI Figure 3. Comparison of DNA translocation events with and without purification. 
MACC1 cDNA samples were prepared as described in SI 1, and amplified by 15 PCR cycles. 
Samples were either subjected to enzymatic digestion following the purification-free method 
and then diluted 1000-fold (a), or purified using a PCR clean-up kit (b). Each sample was 
introduced into a separate nanopore at 300 mV bias (conductance ~9 nS, corresponding to 
~4 nm diameter). Typical concatenated events are shown at the top. An event diagram and a 
histogram of the blockage amplitude are shown in the middle (individual events marked in blue 




SI Figure 4. Data analysis procedure for separating populations of events based on a 
Gaussian mixed model (GMM). a) 2D density plots and their corresponding density 
histograms are generated to determine the initial conditions for the GMM (x: log-scale dwell 
time; y: blockage amplitude). b) The local maxima, marked by red asterisks, are used as initial 
estimations of the means in the GMM. The covariance matrix is then calculated for both of the 
event parameters (blockage amplitude and dwell time). Finally, the mixing proportions are 
estimated as the ratio between the maxima. c) Scatter plots represent the two populations 
recognized by the GMM algorithm, corresponding to the GOI (S100A4, cyan) and the RG 
(G6PDH, magenta). The GMM distribution is shown as a contour plot. d) Color maps show the 





SI Figure 5. Gel electrophoresis of cDNA fragments prepared from CRC cell lines.  50 
ng DNase-treated total RNA was obtained from RKO cells or from the SW480 (non-
metastasizing) or from the SW620 (metastasizing) cell lines. The cDNA fragments were then 
prepared for the GOI (123 bp S100A4 or 360 bp MACC1) and the RG (1231 bp G6PDH) using 
our purification-free method. Negative control samples (-RT) were subjected to the same 
preparation procedure without the RT enzyme. The samples were separated using 4% PAGE 
after 30 cycles of PCR amplification and imaged using the GelDoc EZ (BioRad) after SYBR 





SI Figure 6. Calibration curve of MACC1 for the CRC cell lines samples, obtained by RT-
qPCR. A serial dilution of starting amount of total RNA extracted from SW620 metastasizing 
cell line, between 50 ng to 1.56 ng, were used to form the calibration curve. 
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SI Figure 7. RT-qNP results for MACC1 cDNA samples after optional PCR amplification. 
Nanopore results after PCR amplification of 2 (a, d), 3 (b, e), 5 (c, f), 7 (g, j), 8 (h, k) and 15 
(i, l) cycles, following our purification-free protocol. Each sample was measured using a 
different nanopore. In the first PCR cycle, no amplification occurs, only the second 
complementary strand is synthesized. The top panel of (a-c) and (g-i) shows a scatter plot of 
the translocation events with the corresponding blockage amplitude histograms on the y-axis, 
as well as the concatenated current traces of representative translocation events. (d-f) and (j-
l) show the dwell time histograms (top) and event rate histograms (bottom) from which the 
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capture rate was calculated. Nanopore measurements were taken at 300 mV bias, and the 




SI Figure 8. Amplification curves for MACC1 obtained by RT-qPCR using hybridization 
probes. Duplicate RT-qPCR amplification curves for MACC1 cDNA, obtained from 50 ng total 
RNA extracted from the SW620 metastasizing cell line. The cycle threshold (Ct) was found to 
be 20. 
 
SI Figure 9. Gel electrophoresis of cDNA fragments obtained from SARS-CoV-2 RNA. 
cDNA fragments for each gene were prepared from 500,000 copies of either synthetic SARS-
CoV-2 RNA or 25 ng of DNase-treated total RNA from HCT116 cells. The samples were 
processed using our purification-free method, followed by 30 cycles of PCR amplification for 
visualization purposes. Negative control samples (-RT) underwent the same procedure but 
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without the RTx and Bst 2.0 enzymes. PCR negative control samples (-) contained water 
instead of RT template in the PCR reaction. The ‘No RNA + RT’ samples contained the RTx 
and the Bst 2.0 enzymes but contained water instead of RNA in the RT step. Hence, these 
can be considered as “0 copies” or “0 ng” +RT samples. The samples were separated using 












SI Figure 10. RT-qNP quantification of SARS-CoV-2 RNA against the human reference 
gene RPP30 at three concentration ratios. The composition of each sample is shown at the 
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top. Each sample contained the same amount of RPP30, reverse transcribed from 0.25 ng of 
total RNA from HCT116 cells. The top panels (a-c) show the event diagram with 
representative events. Purple asterisks denote the shorter translocations, which are 
associated with cDNA synthesized from SARS-CoV-2 RNA. The bottom panels (d-e) 
show histograms of the event arrival time, dwell time and current blockage levels. 
 
SI Figure 11. Noise spectra and current-voltage (IV) curves of a nanopore. a) 
Representative noise power spectral density (PSD) versus frequency at an applied bias of 
300mV. b) Representative open pore ionic current versus voltage. A linear I-V curve indicates 
a symmetric nanopore. All ionic currents and noise spectra were measured in a buffer 






SI Figure 12. RT-qNP quantification repeats of the SW480 cell line. 50 ng of total RNA 
underwent cDNA synthesis followed by 5 PCR cycles amplification. Left column and right 
column represent two separate experiments using two nanopores (conductivities 10 nS and 
12 nS, respectively). The top panels (a-b) show the event diagram. The bottom panels (c-






II. Supplementary Tables 
 
SI Table 1. Gene-specific primers used in nanopore sensing experiments and for validation 
of cDNA targets by sequencing. 
*The reverse primers of each PCR primer pair were also used as the primers in each of the 
gene-specific RT reactions. 
 
 
SI Table 2. Gene-specific primers used in RT-qPCR experiments. 
No Gene Oligo Name Sequence (5’---3’) 
1 G6PDH hG6PDH For  ATCGACCACTACCTGGGCAA 
2 hG6PDH_Rev  TTCTGCATCACGTCCCGGA 
3 
MACC1 
hMACC1 For  TTCTTTTGATTCCTCCGGTGA 
4 hMACC1 Rev  ACTCTGATGGGCATGTGCTG 
5 FITC-probe GCAGACTTCCTCAAGAAATTCTGGAAGATCTA 
6 LCRed640-probe AGTGTTTCAGAACTTCTGGACATTTTAGACGA 
7 S100A4 hS100A4 For  GAGCTGCCCAGCTTCTTG 8 hS100A4 Rev  TGCAGGACAGGAAGACACAG 
 
 
SI Table 3. Gene-specific primers used in SARS-CoV-2 experiments. 
No Gene Oligo Name Sequence (5’---3’) 
1 Human RPP30 hRPP30 For AGATTTGGACCTGCGAGC 
2 hRPP30 Rev GACAATCTTCATCTCCTTCTGAT 
3 Viral SARS-
CoV-2 RdRp 
vRdRp For1 GGTAACTGGTATGATTTCGGT 
4 vRdRp Rev1 CTGGTCAAGGTTAATATAGGCATT 
5 Viral SARS-
CoV-2 RdRp 
vRdRp For2 CTCATCAGGAGATGCCAC 
6 vRdRp Rev2 GCAATTTTGTTACCATCAGTAGAT 
  
No Gene Oligo Name Sequence (5’---3’) 
1 G6PDH hG6PDH For ATCGACCACTACCTGGGCAA 2 hG6PDH Rev RT-qNP* TCCTCCTTCCTTCTGTTGGG 
3 MACC1 hMACC1 For RT-qNP* GCACATGCCCATCAGAGTAT 4 hMACC1_Rev RT-qNP* GCTCACAGTGCACGAAAGAT 
5 S100A4 hS100A4 For RT-qNP ACTCCTCTGATGTGGTTGGG 6 hS100A4 Rev RT-qNP* ATCTTTATTGAACTTGCTCAGCATC  
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III. Supplementary Notes 
SI 1: Sample preparation. 
Sample preparation for RT-qPCR of cancer metastasis biomarkers 
Total RNA was isolated using GeneJet RNA Purification Kit (Thermo Fisher scientific), treated 
with DNase I (NEB) and further purified according to the manufacturer’s instructions. 50 ng of 
DNaseI-treated RNA was reverse transcribed with random hexamers in a reaction mix (10 mM 
MgCl2, 1x RT buffer, 250 μM pooled dNTPs, 1 U/μl RNAse inhibitor, and 2.5 U/μl Moloney 
Murine Leukemia Virus reverse transcriptase; all from Thermo Fisher Scientific) using the 
following procedure: incubation at 23°C for 15 min, cDNA synthesis at 42°C for 45 min, 
denaturation at 95°C for 5 min, and cooling at 4°C. The cDNA was amplified by qPCR using 
SYBR Green dye (PerfeCTa SYBR Green Fastmix, Quanta Biosciences) chemistry or 
hybridization probes chemistry (FITC-probe and LCRed-640 probe within the amplicon, see 
SI Table 2) with specific primer-sets for MACC1 or S100A4 as described in SI Table 2. PCR 
was performed under the following conditions: 95°C for 2 min followed by 40 cycles of 95°C 
for 7 s, 60°C for 15 s and 72°C for 20 s.  
Sample preparation for RT-qNP analysis of cancer metastasis biomarkers 
50 ng total RNA was extracted from SW480 or SW620 cell lines, and reverse transcribed with 
specific primers (SI Table 1) for each gene separately or with a combination of desired primers 
in a reaction mix (10 mM MgCl2, 15 pmol of each specific primer, 1x RT buffer, 500 μM pooled 
dNTPs, and 200 U/μl Maxima H Minus Reverse transcriptase, Thermo Fisher Scientific) at 
60°C for 30 min. The reaction was terminated at 85°C for 5 min. Subsequently, cDNA was 
amplified to the specified PCR cycle using Kapa HiFi polymerase (Roche). The amplified 
cDNA was treated with 2.5 U RNase I (Thermo Fisher Scientific) at 37°C for 30 min. Next, the 
sample was treated with 0.2 U ProK (Thermo Fisher Scientific) and 0.2% SDS at 37°C for 30 
min. The sample was diluted twice with the nanopore buffer. 
Sample preparation for RT-qNP analysis of SARS-CoV-2 RNA and hRPP30 
Either DNaseI-treated RNA, extracted from HCT116 cells, or synthetic SARS-CoV-2 RNA 
(control 2; MN908947.3; Twist Biosciences) were reversed transcribed with specific primers 
(SI Table 3) for human RPP30 cDNA or for two amplicons within the RdRp open reading frame 
of SARS-CoV-2. The reaction contained 1x isothermal buffer, 6 mM MgSO4, 1.4 mM dNTPs, 
0.2 µM of each primer, 3 U WarmStartâ RTx (NEB) and 6 U Bst 2.0 WarmStartTM DNA 
polymerase (NEB). The reaction was carried out at 62°C for 30 min. cDNA samples were 
treated with 20 U of Exonuclease I (NEB) at 37°C for 15 min, followed by 2.5 U RNase I 
(Thermo Fisher Scientific) at 37°C for 30 min, and finally 0.2 U of ProK (NEB) in 0.2% SDS for 
30 min. The sample was diluted twice with the nanopore buffer. 
 
SI 2: Optimizing conditions for synthesis and multiplex detection of cDNA targets. 
We performed extensive optimization to achieve high specificity and yield of cDNA products 
for all target genes. G6PDH was selected as a reference gene for both GOIs, based on 
previous studies.1–3 The optimal primer sequences for each of the three genes are 
summarized in Error! Reference source not found.. The corresponding cDNA products were 
123 bp S100A4, 360 bp MACC1 and 1231 bp G6PDH (SI Figure 1). The following optimal 
annealing temperatures were chosen for each cDNA: 58-70°C for MACC1, <68°C for S100A4 




SI 3: Negative control of purification-free assay and nanopore sensing. 
To control for translocation events arising from contaminating background molecules, such as 
enzymes and RNA, we performed nanopore sensing experiments on “-RT” samples. These 
samples underwent the whole process but did not contain the RT enzyme. As demonstrated 
in SI Figure 2, the current trace displayed negligible or no translocation events over extended 
periods of time, showing that the purification-free assay is suitable for detection of cDNA 
reverse transcripts by nanopore sensing. 
 
SI 4: Controls and characteristics of the CRC cell-line sample using multiplex sensing. 
In all the prepared multiplexed samples from the RKO cell line, no bands were observed for 
either of the GOIs (S100A4 or MACC1), as expected (see SI Figure 5). Hence, the RKO cell 
line was used as a negative control for both GOI genes, while the RG band was readily 
obtained, controlling for the sample preparation method. 
 
SI 5: Nanopore fabrication using CBD and characterization  
The solid-state nanopores fabricated in localized thin regions using controlled dielectric 
breakdown (CBD) as previously described4 and were Weibull-distributed. The membrane was 
≤10 nm thick in the area where the pore was formed. Representative noise power spectral 
density (PSD) and current-voltage curves are shown in SI Figure 11. The I-V curve (SI Figure 
11b) shows a symmetric and linear relationship between the current and voltage, supporting 
the formation of symmetric pores. 
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